BioSpace News Archive

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that it has filed an additional four provisional patent applications with the Israel Patent Office, for cannabinoid-based drugs and treatments, designed for conditions associated with non-epileptic seizures and tremors.

To address issues associated with food insecurity during pregnancy for low-income women and their families, the Monsanto Fund (a philanthropic arm of Bayer) and St. Louis-based Operation Food Search are partnering to launch the Fresh Rx: Nourishing Healthy Starts program.

seqWell and Gencove today announced a partnership to bring together seqWell’s plexWell™ library preparation technology and Gencove’s imputation and analysis software to provide genomic researchers a powerful and scalable end-to-end solution for low-pass whole genome sequencing and genotype imputation.

The iQ Group Global, a consortium of life science and financial services companies which span the biopharma value chain from asset discovery to commercialization, today introduced the Saliva Glucose Biosensor.

Kirby Bates Associates, LLC (KBA) is pleased to announce two key strategic hires to support increasing client demand and to enhance the organization’s service offerings.

Camber Spine, a leading innovator in spine and medical technologies, today reported preliminary unaudited proprietary sales results (sales of products innovated and owned by the company) for the fourth quarter and full year ending December 31, 2018.

Jacksonville-based MedMal Direct Insurance Company (MedMal Direct) today announced the appointment of Melodee Dixon as President and Chief Executive Officer. Butler Ball, MedMal Direct’s founding President and CEO, will continue to serve as the CEO of Physicians Trust, Inc., MedMal Direct’s parent company.

Altamont Capital Partners today announced the acquisition of Publicis Healthcare Solutions, a leading pharmaceutical contract commercial services organization, from Publicis Groupe.

The Supreme Cannabis Company, Inc. announced today that its listed securities are expected to commence trading on the Toronto Stock Echange on February 4, 2019.

Accuron Technologies Limited today announced that it will spin out its MedTech business.